Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New test for urinary glucose (BM33071) evaluated.

D L Smalley, M E Bradley

    Clinical Chemistry
    |January 1, 1985
    PubMed
    Summary

    A new test pad for measuring urinary glucose shows excellent agreement with a standard hexokinase method. This glucose oxidase/peroxidase test accurately detects low glucose levels and is unaffected by common interfering substances.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Potent and efficacious inhibition of CXCR2 signaling by biparatopic nanobodies combining two distinct modes of action.

    Molecular pharmacology·2014
    Same author

    A common intracellular allosteric binding site for antagonists of the CXCR2 receptor.

    British journal of pharmacology·2010
    Same author

    SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor.

    British journal of pharmacology·2009
    Same author

    Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2007
    Same author

    Pathogenetic and diagnostic aspects of siliconosis.

    Reviews on environmental health·2002
    Same author

    Purine nucleoside-dependent inhibition of cellular proliferation in 1321N1 human astrocytoma cells.

    The Journal of pharmacology and experimental therapeutics·2001

    Area of Science:

    • Clinical Chemistry
    • Biochemistry
    • Analytical Chemistry

    Background:

    • Accurate measurement of urinary glucose is crucial for diagnosing and monitoring conditions like diabetes mellitus.
    • Existing methods for urinary glucose detection may have limitations in sensitivity or specificity.
    • The Boehringer Mannheim BM33071 test pad offers a novel approach to urinary glucose assessment.

    Purpose of the Study:

    • To evaluate the performance of the new Boehringer Mannheim BM33071 test pad for quantifying urinary glucose.
    • To compare the results obtained from the test pad with a established hexokinase-based method.
    • To determine the sensitivity and specificity of the new test pad, including its susceptibility to interference.

    Main Methods:

    • The study employed the Boehringer Mannheim BM33071 test pad, utilizing a glucose oxidase/peroxidase reaction.
    • Results from the test pad were compared against a reference hexokinase-based analytical method.
    • Interference testing was conducted using acetoacetate, beta-hydroxybutyrate, and human hemoglobin.

    Main Results:

    • A strong correlation was observed between the urinary glucose results obtained from the BM33071 test pad and the hexokinase-based method.
    • The new test pad demonstrated the ability to measure glucose concentrations as low as 260 mg/L.
    • No significant interference was found from acetoacetate, beta-hydroxybutyrate, or human hemoglobin.

    Conclusions:

    • The Boehringer Mannheim BM33071 test pad provides a reliable and accurate method for measuring urinary glucose.
    • The test pad exhibits high sensitivity, capable of detecting clinically relevant low concentrations of glucose.
    • Its lack of interference from common substances enhances its utility in diverse clinical settings.

    Related Experiment Videos